Alkermes plc. (ALKS) cash flow statement
ALKSNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 5/30132% above fair value
$44.94−1.24 (-2.69%)
Close on Nov 20, 2026Market cap $7.54BP/E 118.3Yield –
Alkermes plc. cash flow statement
Ratios
Latest available, balances at Jun 30, 2026
Profitability, TTM
- Gross margin
- 84.6%
- Operating margin
- 7.0%
- Net margin
- 4.0%
- Return on equity, FY2025
- 14.7%
Financial strength
- Current ratio
- 2.30
- Debt to equity
- 0.83
- Debt to assets
- 34.2%
- Cash to current liabilities
- 77.3%
Valuation
- P/E ratio
- 118.3
- Price to sales
- 4.52
- Price to book
- 4.17
- Dividend yield
- –
See a number that looks wrong?